✦ LIBER ✦

Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma

✍ Scribed by Gordon, Susan J.; Pearson, Andrew D.J.; Reid, Michael M.; Craft, Alan W.

Book ID: 121936550
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 567 KB
Volume: 28
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(92)90508-Y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pilot study of high-dose vincristine, et

Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastoma

✍ Corbett, Robin; Pinkerton, Ross; Pritchard, Jon; Meller, Simon; Lewis, Ian; King 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 633 KB

Single institution experience with high-

Single institution experience with high-dose cyclophosphamide, continuous infusion vincristine, escalating doses of VP-16-213, and total body irradiation with unpurged bone marrow rescue in children with neuroblastoma

✍ Kletzel, Morris ;Becton, David L. ;Berry, D. H. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

## Abstract Seven consecutive autologous bone marrow transplants were performed in children with neuroblastoma with very good partial remission (VGPR). A combination of cyclophosphamide, escalating doses of VP‐16‐213, continuous infusion vincristine, and total body irradiation followed by infusion

Intensive chemotherapy with high doses o

Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies

✍ M. H. Gaspard; D. Maraninchi; A. M. Stoppa; J. A. Gastaut; G. Michel; N. Tubiana 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 688 KB

Twenty-six patients (median age 33 years) with poor-risk malignancies were treated with high-dose combination chemotherapy associating BCNU-etoposide-cytosine arabinoside and melphalan (BEAM) followed by autologous bone marrow transplantation (ABMT). Twenty-one patients had malignant lymphomas, thre